La description :amplycell's technology increases cell line productivity and stability, allowing cost-effective and efficient manufacturing of recombinant protein and antibody....
Classement Alexa Global: # 14,996,306
Server:nginx...
L'adresse IP principale: 52.210.189.158,Votre serveur United States,Wilmington
ISP:E.I. du Pont de Nemours and Co. Inc. TLD:com Code postal:us
Ce rapport est mis à jour en 29-Aug-2018
Created Date:
2014-12-24
Changed Date:
2017-07-26
Données techniques du amplycell.com
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations.
Notre service GeoIP a trouvé l'hôte amplycell.com.Actuellement, hébergé dans United States et son fournisseur de services est E.I. du Pont de Nemours and Co. Inc. .
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé nginx contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
IP:52.210.189.158 ASN:16509 OWNER:AMAZON-02 - Amazon.com, Inc., US Country:US
mx:
MX preference = 10, mail exchanger = mx1.jimdo.com. MX preference = 20, mail exchanger = mx2.jimdo.com.
HtmlToText
homepage amply™ technology timelines similarity stability quality system amply™ cell lines amply™cho cells amply™hybridoma amply™hek293 biotech pharma applications biosimilars difficult to express proteins new biological entities ivd about us meet with us amplycell team partners corporate leadership contact news homepage amply™ technology timelines similarity stability quality system amply™ cell lines amply™cho cells amply™hybridoma amply™hek293 biotech pharma applications biosimilars difficult to express proteins new biological entities ivd about us meet with us amplycell team partners corporate leadership contact news homepage produce your biomolecules cheaper and quicker, thanks to cell line optimization biologic drug developments markets such as monoclonal antibodies, biosimilars, gene therapy , are highly growing while all developers need to decrease their cost of goods and reach market as quick as possible. at amplycell we have developed the amply™ technology that makes it possible to produce biomolecules and drugs at affordable cost. we directly adress the holy cow of biopharma industry, their cell lines used for their bioproduction, making them up to 10x more profitable in terms of yield and even more in term of financial profit. amply™technology is based on physical stimulation treatments that activate cell line metabolism and productivity in a permanent way. by applying on cell lines such as chinese hamster ovary (cho), human embryonic kidney (hek293) and hybridomas , it allows cost-effective and efficient gmp manufacturing of recombinant proteins, difficult-to-express new biological entities, biosimilars drugs and viral vectors. discover amply™technology for cell line optimization cell lines to stimulate with amply™technology application of high-productivity cells in the biopharma industry follow amplycell on social media amplycell s.a. | 5 avenue hippocrate | 4000 liège +32 (0)4 266 94 93 info@amplycell.com mentions légales | politique de confidentialité | politique des cookies | plan du site connexion déconnecter | modifier fermer
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR PSI-USA, Inc. dba Domain Robot
SERVERS
SERVER com.whois-servers.net
ARGS domain =amplycell.com
PORT 43
TYPE domain RegrInfo DOMAIN
NAME amplycell.com
CHANGED 2017-07-26
CREATED 2014-12-24
STATUS clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Nous utilisons des cookies pour personnaliser votre expérience sur notre site. En poursuivant votre navigation, vous acceptez cette utilisation. Apprendre encore plus
amplycell.com rapport :
Visitez le site